Olin (OLN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 net income was $74.2M ($0.62/diluted share), down from $146.9M ($1.13/diluted share) in Q2 2023, mainly due to weaker chemical segment results, partially offset by Winchester growth and White Flyer acquisition.
Adjusted EBITDA for Q2 2024 was $278.1M, up 15% sequentially but down from $351.1M in Q2 2023.
Q2 unfolded as expected, with modest improvement in chemical businesses due to seasonal demand and better pricing, while Winchester met objectives with strong military and White Flyer performance.
Hurricane Beryl caused significant disruption at the Freeport, Texas facility, but safety protocols limited impact and most plants have resumed operation.
Repurchased 3.9M shares (~3% of outstanding) year-to-date, including $106M in Q2 2024.
Financial highlights
Q2 2024 sales were $1.64B, down 3% year-over-year; gross margin was $237.8M (14% of sales), down from $310.1M (18%) in Q2 2023.
Q2 2024 operating income was $136.4M, down from $216.7M in Q2 2023.
Ended Q2 with $182.1M in cash and about $1B in available liquidity.
Net debt increased by $229M from year-end, mainly due to seasonal working capital build; net debt to Adjusted EBITDA ratio at 2.6x.
Deferred $80M in international tax payments to 2025.
Outlook and guidance
Hurricane Beryl expected to impact chemicals businesses by ~$100M in Q3 2024, with no insurance recovery anticipated.
Full-year 2024 Adjusted EBITDA outlook lowered to ~$940M, including hurricane impact; excluding hurricane, guidance is ~$1.04B.
Working capital and net debt at year-end 2024 expected to be similar to 2023.
2024 capital spending forecasted at ~$225M, including $10M for hurricane recovery.
Winchester Q3 2024 results expected to improve on stronger commercial and military demand.
Latest events from Olin
- Q3 2025 returned to profit on higher sales and tax credits, but segment challenges persist.OLN
Q3 20259 Jul 2026 - Q2 2025 net loss and margin pressure despite higher sales; Q3 EBITDA guided $170–$210M.OLN
Q2 20258 Jul 2026 - Q4 2024 EBITDA was $193M; AMMO, Inc. asset deal and PVC resin entry drive future growth.OLN
Q4 20248 Jul 2026 - $12B+ merger creates a chemicals leader with $400M+ synergies and strong integration.OLN
M&A announcement16 Jun 2026 - Q1 2026 posted an $83M net loss; Q2 EBITDA is forecasted at $160–$200M with improved outlook.OLN
Q1 20268 May 2026 - Q4 2025 delivered a net loss and lower EBITDA, but cost actions support gradual 2026 improvement.OLN
Q4 202510 Apr 2026 - Key votes on directors, executive pay, new incentive plan, and auditor highlight governance and ESG focus.OLN
Proxy filing20 Mar 2026 - Annual meeting proxy materials filed; no filing fee required.OLN
Proxy filing20 Mar 2026 - Q3 net loss from hurricane and weak demand, but caustic soda prices and military sales improved.OLN
Q3 202418 Jan 2026